Methadone Maintenance and HIV Prevention: A Cost-Effectiveness Analysis

摘要

We assess the cost-effectiveness of maintenance treatment for heroin addition, with emphasis on its role in preventing HIV infection. The analysis is based on a dynamic compartmental model of the HIV epidemic among a population of adults, ages 18 to 44. The population is divided into nine compartments according to infection status and risk group. The model takes into account disease transmission from drug injection and sexual contacts. The health benefits of methadone maintenance and the resulting HIV infections averted are measured in terms of life years gained and quality-adjusted life years gained. Costs considered include all health-care costs (including cost of HIV care the other health care) and the cost of methadone maintenance. The analysis shows that expanding existing methadone maintenance programs is a cost-effective health-care intervention that can play an important role in slowing the spread of HIV and improving the length and quality of life for injection drug users (IDUs), and that such expansion is cost-effective even in populations with low HIV prevalence among IDUs. Incremental expansion of methadone maintenance programs was found to have a cost-effectiveness ratio of between